These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 23376977)

  • 1. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
    Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
    Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.
    Frommeyer G; Schmidt M; Clauß C; Kaese S; Stypmann J; Pott C; Eckardt L; Milberg P
    Eur J Heart Fail; 2012 Dec; 14(12):1322-31. PubMed ID: 23099358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological profile of vernakalant in an experimental whole-heart model: the absence of proarrhythmia despite significant effect on myocardial repolarization.
    Frommeyer G; Milberg P; Clauss C; Schmidt M; Ramtin S; Kaese S; Grundmann F; Grotthoff JS; Pott C; Eckardt L
    Europace; 2014 Aug; 16(8):1240-8. PubMed ID: 24696223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits.
    Aidonidis I; Doulas K; Hatziefthimiou A; Tagarakis G; Simopoulos V; Rizos I; Tsilimingas N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):94-101. PubMed ID: 22872232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranolazine terminates atrial flutter and fibrillation in a canine model.
    Bhimani AA; Yasuda T; Sadrpour SA; Khrestian CM; Lee S; Zeng D; Belardinelli L; Waldo AL
    Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
    Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
    J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
    Burashnikov A; Di Diego JM; Barajas-Martínez H; Hu D; Cordeiro JM; Moise NS; Kornreich BG; Belardinelli L; Antzelevitch C
    Circ Heart Fail; 2014 Jul; 7(4):627-33. PubMed ID: 24874201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
    Burashnikov A; Belardinelli L; Antzelevitch C
    J Pharmacol Exp Ther; 2012 Jan; 340(1):161-8. PubMed ID: 22005044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
    He Z; Sun C; Xu Y; Cheng D
    Biomed Pharmacother; 2016 Dec; 84():1760-1767. PubMed ID: 27847200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
    Frommeyer G; Kaiser D; Uphaus T; Kaese S; Osada N; Rajamani S; Belardinelli L; Breithardt G; Eckardt L; Milberg P
    Heart Rhythm; 2012 Dec; 9(12):2051-8. PubMed ID: 23044390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
    Frommeyer G; Sterneberg M; Dechering DG; Kaese S; Bögeholz N; Pott C; Fehr M; Bogossian H; Milberg P; Eckardt L
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
    Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart.
    Carvas M; Nascimento BC; Acar M; Nearing BD; Belardinelli L; Verrier RL
    J Cardiovasc Pharmacol; 2010 Mar; 55(3):286-91. PubMed ID: 20075744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine Prevents Levosimendan-Induced Atrial Fibrillation.
    Ellermann C; Kohnke A; Dechering DG; Kochhäuser S; Reinke F; Fehr M; Eckardt L; Frommeyer G
    Pharmacology; 2018; 102(3-4):138-141. PubMed ID: 29982246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.